Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 9, 2007
[Reassessment of T classification system cutoff value for renal cell carcinoma]Takashi Obara, Shinobu Matsuura, Takamitsu Inoue, et al.
Urology|February 19, 2010
Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patientsTakeshi Yuasa, Shinya Maita, Norihiko Tsuchiya, et al.
Cancer|January 19, 2012
Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer methodEmiko Sugawara, Yuki Togashi, Naoto Kuroda, et al.
Proteomics. Clinical Applications|December 8, 2010
A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinomaSusumu Kageyama, Hideaki Iwaki, Hirokazu Inoue, et al.
Urology|November 8, 2011
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxelMasaya Ito, Kazutaka Saito, Yosuke Yasuda, et al.
British Journal of Haematology|August 16, 2005
Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growthHidekazu Segawa, Shinya Kimura, Junya Kuroda, et al.
International Journal of Cancer|September 24, 2004
Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from calophyllum brasiliense that acts by induction of apoptosisShinya Kimura, Chihiro Ito, Naoto Jyoko, et al.
Clinical and Experimental Nephrology|February 9, 2008
Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimusMitsuru Saito, Shigeru Satoh, Hideaki Kagaya, et al.
Cancer Medicine|December 27, 2022
Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practiceIzuma Nakayama, Eiji Shinozaki, Hiroshi Kawachi, et al.
International Journal of Clinical Oncology|July 23, 2017
Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.
Pageof 22